Finance
AstraZeneca in Merger Talks With Bristol Myers Squibb
AstraZeneca has held talks with Bristol Myers Squibb over a merger that could create a £300billion pharmaceutical giant.
MarketsIndicesCommoditiesFXRates
AstraZeneca has held talks with Bristol Myers Squibb over a merger that could create a £300billion pharmaceutical giant.
